Korbinian L÷bmann
Korbinian L÷bmann
Associate Professor, K°benhavns Universitet
Email verificata su sund.ku.dk
Titolo
Citata da
Citata da
Anno
Emerging trends in the stabilization of amorphous drugs
R Laitinen, K L÷bmann, CJ Strachan, H Grohganz, T Rades
International journal of pharmaceutics 453 (1), 65-79, 2013
3622013
Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen
K Löbmann, R Laitinen, H Grohganz, KC Gordon, C Strachan, T Rades
Molecular pharmaceutics 8 (5), 1919-1928, 2011
2902011
Recent advances in co-amorphous drug formulations
SJ Dengale, H Grohganz, T Rades, K L÷bmann
Advanced drug delivery reviews 100, 116-125, 2016
2672016
Amino acids as co-amorphous stabilizers for poorly water soluble drugs–Part 1: Preparation, stability and dissolution enhancement
K L÷bmann, H Grohganz, R Laitinen, C Strachan, T Rades
European journal of pharmaceutics and biopharmaceutics 85 (3), 873-881, 2013
2272013
Co-amorphous simvastatin and glipizide combinations show improved physical stability without evidence of intermolecular interactions
K L÷bmann, C Strachan, H Grohganz, T Rades, O Korhonen, R Laitinen
European Journal of Pharmaceutics and Biopharmaceutics 81 (1), 159-169, 2012
1812012
Amino acids as co-amorphous stabilizers for poorly water-soluble drugs–Part 2: Molecular interactions
K L÷bmann, R Laitinen, C Strachan, T Rades, H Grohganz
European Journal of Pharmaceutics and Biopharmaceutics 85 (3), 882-888, 2013
1352013
Refining stability and dissolution rate of amorphous drug formulations
H Grohganz, PA Priemel, K L÷bmann, LH Nielsen, R Laitinen, A Mullertz, ...
Expert opinion on drug delivery 11 (6), 977-989, 2014
1122014
A theoretical and spectroscopic study of co-amorphous naproxen and indomethacin
K L÷bmann, R Laitinen, H Grohganz, C Strachan, T Rades, KC Gordon
International journal of pharmaceutics 453 (1), 80-87, 2013
1032013
Comparative study of different methods for the prediction of drug–polymer solubility
MM Knopp, L Tajber, Y Tian, NE Olesen, DS Jones, A Kozyra, K Lobmann, ...
Molecular pharmaceutics 12 (9), 3408-3419, 2015
992015
Preparation and characterization of spray-dried co-amorphous drug–amino acid salts
KT Jensen, LI Blaabjerg, E Lenz, A Bohr, H Grohganz, P Kleinebudde, ...
Journal of Pharmacy and Pharmacology 68 (5), 615-624, 2016
912016
Improving co-amorphous drug formulations by the addition of the highly water soluble amino acid, proline
KT Jensen, K L÷bmann, T Rades, H Grohganz
Pharmaceutics 6 (3), 416-435, 2014
912014
Predicting crystallization of amorphous drugs with terahertz spectroscopy
J Sibik, K Löbmann, T Rades, JA Zeitler
Molecular pharmaceutics 12 (8), 3062-3068, 2015
862015
Amino acids as co-amorphous excipients for simvastatin and glibenclamide: physical properties and stability
R Laitinen, K Lobmann, H Grohganz, C Strachan, T Rades
Molecular pharmaceutics 11 (7), 2381-2389, 2014
862014
Formation mechanism of coamorphous drug–amino acid mixtures
KT Jensen, FH Larsen, C Cornett, K Löbmann, H Grohganz, T Rades
Molecular pharmaceutics 12 (7), 2484-2492, 2015
712015
Glass-transition temperature of the β-relaxation as the major predictive parameter for recrystallization of neat amorphous drugs
EO Kissi, H Grohganz, K Löbmann, MT Ruggiero, JA Zeitler, T Rades
The Journal of Physical Chemistry B 122 (10), 2803-2808, 2018
682018
Supersaturating drug delivery systems: the potential of co-amorphous drug formulations
R Laitinen, K L÷bmann, H Grohganz, P Priemel, CJ Strachan, T Rades
International journal of pharmaceutics 532 (1), 1-12, 2017
662017
Cellulose nanofibers as excipient for the delivery of poorly soluble drugs
K L÷bmann, AJ Svagan
International journal of pharmaceutics 533 (1), 285-297, 2017
652017
Solid-state properties and dissolution behaviour of tablets containing co-amorphous indomethacin–arginine
E Lenz, KT Jensen, LI Blaabjerg, K Knop, H Grohganz, K L÷bmann, ...
European Journal of Pharmaceutics and Biopharmaceutics 96, 44-52, 2015
652015
Improvement of dissolution rate of indomethacin by inkjet printing
H Wickstr÷m, M Palo, K Rijckaert, R Kolakovic, JO Nyman, A Mńńttńnen, ...
European Journal of Pharmaceutical Sciences 75, 91-100, 2015
582015
Development of a screening method for co-amorphous formulations of drugs and amino acids
G Kasten, H Grohganz, T Rades, K L÷bmann
European Journal of Pharmaceutical Sciences 95, 28-35, 2016
562016
Il sistema al momento non pu˛ eseguire l'operazione. Riprova pi¨ tardi.
Articoli 1–20